Archived Facts

(Reuters) – Gilead Sciences Inc on Saturday reported a 100 percent cure rate using a combination of drugs in a small number of patients with the most common and hardest to treat form of hepatitis C.

Popular Posts:

Incoming search terms:

Related Posts:

Leave a Reply